Application of Dynamic Susceptibility Contrast-Enhanced MR Imaging in Evaluation of Brain Tumor after Operation
10.3969/j.issn.1002-1671.2009.12.002
- VernacularTitle:动态磁敏感对比增强磁共振成像在脑肿瘤术前评估中的应用
- Author:
Jichao ZHU
;
Mingwu LOU
;
Fangjing ZHANG
;
Weidong HU
;
Yi FAN
;
Yanping CHEN
- Publication Type:Journal Article
- Keywords:
brain;
tumor;
dynamic susceptibility contrast-enhanced;
MR perfusion imaging
- From:
Journal of Practical Radiology
2009;25(12):1698-1702
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the value of dynamic susceptibility contrast-enhanced MR imaging (DSC)in evaluation of brain tumor after operation.Methods 41 cases with brain tumors verified histologically,including 8 cases of high-grade gliomas,16 of low-grade gliomas,7 of metastases and 10 of meningiomas underwent DSC examination.All the cases at 3.0T MR unit.All primitive data were sent to ADW4.3 workstation for post-processing.The mean maximal rCBV and rCBF ratios of tumors,1 cm and 2 cm regions of peri-tumor were obtained respectively.The relativity of MR perfusion parameters(rCBV and rCBF)between diferent tumors were statistically evaluated by using Pearson correlative analysis.Results In the solid region of tumors,rCBV and rCBF were statistically significant differences (P<0.05)between low-grade gliomas and the other three groups of tumors; in 1 cm region of peri-tumor between high-grade gliomas and the other three groups,and between low-grade gliomas and metastases,between the solid region and both regions of 1 cm and 2 cm peri-tumors at the same tumor were all of statistically significant differences(P<0.05),between 1 cm and 2 cm region of peri-tumors at high-grade gliomas and metastases,the rCBV and rCBF were also of statistically significant differences.Pearson correlative analysis showed that there were significant positive correlations between the mean maximal rCBV and rCBF ratios at the same region in the same tumor's group.Conclusion DSC is very valuable in evaluation of the histopathological grade and the differentiation of brain tumor.
